Gastrointestinal release behaviour of modified-release drug products: Dynamic dissolution testing of mesalazine formulations-Reference-Cited by-同舟云学术

Gastrointestinal release behaviour of modified-release drug products: Dynamic dissolution testing of mesalazine formulations

Published:2015-04 Issue:1-2 Volume:484 Page:103-108
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Goyanes Alvaro,Hatton Grace B.,Merchant Hamid A.,Basit Abdul W.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference39 articles.

1. 5-ASA colonic mucosal concentrations resulting from different pharmaceutical formulations in ulcerative colitis;D’Inca;World J. Gastroenterol.,2013

2. Transit of pharmaceutical dosage forms through the small intestine;Davis;Gut,1986

3. eMC-Asacol, 2014. Summaries of product characteristics: Asacol 800mg MR tablets. https://www.medicines.org.uk/emc/medicine/20478 (accessed 12.10.14.).

4. eMC-Mezavant, 2014. Summaries of product characteristics: Mezavant XL 1200, gastro-resistant, prolonged release tablets. https://www.medicines.org.uk/emc/medicine/20347 (accessed 12.10.14.).

5. eMC-Salofalk, 2014. Summaries of product characteristics: Salofalk 500mg gastro-resistant prolonged-release granules. https://www.medicines.org.uk/emc/medicine/16909 (accessed 12.10.14.).

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MMX mesalamine in ulcerative colitis: Major advantages towards classical mesalamine formulations;Digestive and Liver Disease;2024-09

2. Effect of postprandial gastric conditions on in vitro drug release from modified release mesalamine formulations;Journal of Drug Delivery Science and Technology;2024-09

3. Colon targeting in rats, dogs and IBD patients with species-independent film coatings;International Journal of Pharmaceutics: X;2024-06

4. Nano-curcumin formulations for targeted therapy of colorectal cancer;Journal of Drug Delivery Science and Technology;2023-10

5. Comparison of 5-ASA layered or matrix pellets coated with a combination of ethylcellulose and eudragits L and s in the treatment of ulcerative colitis in rats;International Journal of Pharmaceutics;2023-06